Understanding Large Molecule Drug Development: From Biologics to Market
Syner-G
SEPTEMBER 15, 2023
This shift from a linear to a network approach enhances the potential for one drug to target multiple sites. Structure-based drug design has evolved, facilitating the exploration of novel chemical probes and lead compound potency, and molecular docking utilizes target structures to predict interactions and offers simplicity and speed.
59 
Let's personalize your content